Healthcare · Pharmaceuticals & Biotechnology
No company profile on record yet.
| Fiscal year | Mar 26 | Mar 25 | Mar 24 | Mar 23 | Mar 22 |
|---|---|---|---|---|---|
| Total income (before exceptional items) | 181† | 172† | 157† | 174† | 136† |
| Net profit | 11 | 7 | 8† | 19† | 14† |
₹ Crore. † Summed from the four quarterly filings of that fiscal year.
Current board roster from exchange filings. Director remuneration is not in our data, so it isn't shown.
| Name | Designation | Term end |
|---|---|---|
| Laxminarayan Moondra | Executive Director | June 30, 2026 |
| Sathyanarayana Mundra | Executive Director | June 30, 2026 |
| Sunil Laxminarayana Mundra | Executive Director | June 30, 2026 |
| Pramod Kasat | Independent Director | June 30, 2026 |
| Shirish Gundopant Belapure | Independent Director | June 30, 2026 |
| Tekkar Yashwanth Prabhu | Independent Director | June 30, 2026 |
| Jyoti Mundra | Non-Executive Director | June 30, 2026 |
| Sushil Kumar Mundra | Non-Executive Director | June 30, 2026 |
Key management names, their remuneration, subsidiaries and brand listings are not in the exchange filings we ingest yet, so they are not shown here rather than estimated.
